David Ben-Ami

Meytav is a venture capital investment manager following a hands-on investment approach. It focuses on early-stage businesses in the life sciences sector, particularly biopharmaceuticals and medical device technology. It provides a wide range of support services to their portfolio companies, including incubator space for two to three years, office services, strategic advisory, planning and budgeting assistance, and access to an established network of business partners. Meytav targets projects based on innovation in the medical field. It leverages their close proximity with Upper Galilee research centers including MIGAL, specialized in agriculture and biotechnology, and the Tel Hai Community College. Each project is structured as an independent company co-owned by the entrepreneurs, the financing partners and Meytav's holding company. It promotes the growth of their investee companies through IP portfolio development and the establishment of partnerships for R&D, clinical development, manufacturing and commercialization worldwide.

Manufactures medical catheters, silicone medical products and medical devices for critical care and operating rooms

Develops a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers and venous leg ulcers

Manufactures flu medicines

Engages in the development, manufacturing and marketing of hair restoration devices

Novolog Ltd. operates as a distribution company, which includes pharmaceutical, general health products, and disposable medical devices. Its partners include pharmaceutical and medical device companies. The company was founded in 1966 and is headquartered in Modiin, Israel.

Manufactures vein treatment devices

Manufactures medical devices

Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases

Wholesales pharmaceutical products

Joy Ventures invests in companies located in Israel. The firm focuses on neuro-wellness technology including consumer products, applications and food substances. It participates in seed, early and later stage capital transactions.

Corundum Open Innovation Ltd. is an active manager.

Manufactures dialysis solutions, disposable bags and medical products

Provides investment services

Operates as a clinical stage biotechnology company transforming the fight against neurodegeneration and aging by targeting the immune systems

Develops pharmaceutical products for ophthalmic company

SBI JI Innovation Advisor invests in companies located in Israel and Asia. The firm targets companies operating in bio science companies. It provides financing in early stage capital requirements.